FDA Approved: TECHNETIUM TC 99M MEDRONATE — Supplemental Application (Jubilant DraxImage Inc., dba Jubilant Radiopharma)

View source ↗

Summary

FDA approved a supplemental application for Technetium Tc-99m Medronate (bone imaging agent) submitted by Jubilant DraxImage Inc., dba Jubilant Radiopharma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Fracture
• Bone Metastases
• Osteomyelitis

Drugs mentioned

• Technetium Tc-99m Medronate (Technetium Tc-99m Medronate)

Snippet

SUPPL AP for TECHNETIUM TC 99M MEDRONATE (TECHNETIUM TC 99M MEDRONATE)